DRMAW vs MTD
Dermata Therapeutics Inc. Warrant (DRMAW) versus Mettler-Toledo International Inc (MTD) — a side-by-side from cached financials, not a winner call.
Dermata Therapeutics Inc. Warrant (DRMAW) common stock listed on NASDAQ.
Mettler-Toledo International Inc (MTD) is a diagnostics & research company listed on NYSE.
DRMAW does not have a complete income-statement cache yet.
Latest reported MTD revenue for 2026-06-30 was $1.97B. Net income was $402.4M. MTD currently screens at market cap $23.20B and trailing P/E 26.9.
DRMAW currently screens at market cap $0. MTD currently screens at market cap $23.20B and trailing P/E 26.9.
Not investment advice. Open the DRMAW and MTD stock pages for the full models.
Not investment advice.